Every recall we track for IBSA PHARMA INC — 15 in all — plus the complaints and injury reports the public filed about them.
IBSA Pharma recalls TIROS: levothyroxine oral solution with subpotent drug risk. Affected units have NDC 71858-0110-5, lot 220856, expiring 2/2024. No remedy specified in recall notice.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (50 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy details.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (44 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Consumers should contact pharmacy for guidance.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (13 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Consumers should contact pharmacy for guidance.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (100 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (88 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for return instructions.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (125 mcg/mL) with potential subpotent drug levels. This may not provide adequate thyroid hormone. Affected units have NDC 71858-0140-5 and lot 220855.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (37.5 mcg/mL) with subpotent drug risk. This affects specific lots manufactured in Switzerland. Contact for return instructions.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (112 mcg/mL) with subpotent drug risk. Affected lots manufactured in 2023-2024 may cause inadequate thyroid hormone levels.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (175 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Consumers should contact pharmacy for guidance.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (62.5 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for return instructions.
IBSA Pharma recalls TIROS: levothyroxine oral solution with subpotent drug risk. This medication may not provide proper thyroid hormone levels. Affected units have NDC 71858-0150-5 and lot #220959.
IBSA Pharma recalls TIROS: levothyroxine oral solution with subpotent drug risk. This may not provide proper thyroid hormone levels. Consumers should contact pharmacy for guidance.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (137 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Consumers should contact pharmacy for guidance.
IBSA Pharma recalls TIROSINT levothyroxine oral solution (200 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy details.
